Profile data is unavailable for this security.
About the company
NIPPON CHEMIPHAR CO., LTD. is a Japan-based company centered on ethical pharmaceutical products and mainly engaged in the pharmaceutical, health and beauty related businesses. The Company’s Pharmaceutical segment is engaged in the manufacture and sale of ethical pharmaceutical products. Other businesses include entrusted safety testing, healthcare and real estate leasing business. The Company mainly operates in Japan and Vietnam.
- Revenue in JPY (TTM)30.61bn
- Net income in JPY-241.00m
- Incorporated1950
- Employees872.00
- LocationNippon Chemiphar Co Ltd2-2-3, Iwamoto-choCHIYODA-KU 101-0032JapanJPN
- Phone+81 338631211
- Fax+81 338645940
- Websitehttps://www.chemiphar.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solasia Pharma KK | 617.00m | -1.11bn | 4.89bn | 24.00 | -- | 2.41 | -- | 7.92 | -6.61 | -6.61 | 3.67 | 10.78 | 0.2301 | 4.10 | 1.93 | 25,708,330.00 | -41.51 | -48.57 | -47.74 | -58.83 | 54.78 | 71.01 | -180.39 | -300.89 | 2.91 | -- | 0.031 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
| KAINOS Laboratories, Inc. | 4.98bn | 647.70m | 5.48bn | 144.00 | 7.76 | 0.8196 | 7.11 | 1.10 | 154.88 | 154.88 | 1,192.40 | 1,466.62 | 0.605 | 2.89 | 3.13 | 34,615,160.00 | 7.86 | 6.66 | 10.25 | 9.07 | 51.41 | 51.52 | 12.99 | 9.89 | 2.53 | -- | 0.1133 | 17.01 | 6.69 | 2.33 | 10.90 | 15.37 | -46.23 | 14.87 |
| Cyfuse Biomedical KK | 61.11m | -589.21m | 5.52bn | 21.00 | -- | 1.72 | -- | 90.25 | -75.45 | -75.45 | 7.82 | 405.80 | 0.0135 | 0.5407 | 3.98 | 2,910,095.00 | -13.05 | -- | -15.34 | -- | 61.76 | -- | -964.15 | -- | 5.92 | -71.55 | 0.2218 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
| Kidswell Bio Corp | 2.62bn | -1.21bn | 5.96bn | 41.00 | -- | 4.07 | -- | 2.28 | -37.72 | -37.72 | 77.56 | 37.57 | 0.5583 | 1.26 | 4.00 | 63,807,830.00 | -25.82 | -58.77 | -36.65 | -77.44 | 50.30 | 59.87 | -46.25 | -139.31 | 1.86 | -21.98 | 0.6118 | -- | 76.92 | 21.24 | -22.83 | -- | -- | -- |
| Delta-Fly Pharma Inc | 0.00 | -1.26bn | 6.73bn | 11.00 | -- | 3.99 | -- | -- | -187.93 | -187.93 | 0.00 | 205.25 | 0.00 | -- | -- | 0.00 | -92.45 | -53.35 | -103.56 | -55.60 | -- | -- | -- | -769.75 | -- | -391.17 | 0.00 | -- | -100.00 | -- | -37.37 | -- | -- | -- |
| CellSeed Inc | 190.13m | -846.53m | 6.79bn | 35.00 | -- | 3.07 | -- | 35.70 | -29.28 | -29.28 | 6.61 | 68.81 | 0.0948 | 1.62 | 4.90 | 5,432,400.00 | -42.22 | -49.69 | -45.69 | -54.55 | 56.36 | 63.66 | -445.23 | -428.62 | 18.66 | -601.01 | 0.0653 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| K Pharma Inc | 1.00bn | 260.33m | 6.80bn | 15.00 | 25.81 | 2.19 | -- | 6.80 | 22.71 | 22.71 | 86.17 | 267.55 | -- | -- | -- | 66,666,670.00 | -- | -- | -- | -- | 91.00 | -- | 26.03 | -- | 18.48 | -- | 0.00 | -- | -- | -- | 166.34 | -- | -- | -- |
| NIPPON CHEMIPHAR CO., LTD. | 30.61bn | -241.00m | 6.88bn | 872.00 | -- | 0.3107 | 5.76 | 0.2247 | -66.77 | -66.77 | 8,482.42 | 5,194.10 | 0.6063 | 2.09 | 2.65 | 35,106,650.00 | -0.4793 | 1.20 | -0.6777 | 1.74 | 25.09 | 34.53 | -0.7905 | 1.77 | 1.61 | -- | 0.4852 | 38.20 | -2.91 | -2.23 | -51.57 | -21.81 | -13.06 | -12.94 |
| Noile-Immune Biotech Inc | 316.82m | -1.13bn | 7.18bn | 28.00 | -- | 1.26 | -- | 22.68 | -26.14 | -26.14 | 7.32 | 131.42 | 0.0608 | 0.1818 | -- | 11,314,930.00 | -21.69 | -- | -22.60 | -- | 99.29 | -- | -356.68 | -- | 66.04 | -- | 0.00 | -- | -49.37 | -- | -192.28 | -- | -- | -- |
| Chiome Bioscience Inc | 682.46m | -1.22bn | 7.24bn | 51.00 | -- | 5.91 | -- | 10.61 | -24.67 | -24.67 | 13.77 | 22.00 | 0.3441 | 4.19 | 6.88 | 13,381,650.00 | -61.51 | -50.50 | -79.81 | -57.38 | 58.41 | 57.53 | -178.77 | -224.74 | 2.90 | -513.93 | 0.2009 | -- | 8.19 | 26.24 | 1.84 | -- | -- | -- |
| DNA Chip Research Inc | 431.66m | -284.71m | 7.56bn | 36.00 | -- | 15.01 | -- | 17.51 | -45.19 | -45.19 | 68.77 | 74.44 | 0.6728 | 8.52 | 5.31 | 11,990,420.00 | -44.38 | -21.72 | -55.27 | -24.43 | 6.02 | 17.16 | -65.96 | -50.03 | 1.90 | -- | 0.00 | -- | -23.46 | -2.03 | -170.31 | -- | 33.58 | -- |
| Carna Biosciences, Inc. | 1.63bn | -1.15bn | 7.72bn | 67.00 | -- | 1.99 | -- | 4.75 | -69.84 | -69.84 | 96.78 | 226.16 | 0.3774 | 1.36 | 3.35 | 24,267,000.00 | -26.76 | -14.45 | -29.55 | -16.95 | 89.22 | 90.59 | -70.91 | -35.42 | 10.78 | -312.97 | 0.0451 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
| Wakamoto Pharmaceutical Co Ltd | 7.98bn | -177.67m | 7.98bn | 292.00 | -- | 0.6792 | 34.30 | 0.9999 | -5.12 | -5.12 | 229.89 | 337.15 | 0.525 | 2.08 | 2.88 | 27,324,600.00 | -1.17 | -2.58 | -1.34 | -3.00 | 46.98 | 53.08 | -2.23 | -4.33 | 3.45 | -- | 0.0085 | -- | 3.31 | -4.50 | -42.04 | 1.88 | -17.49 | 0.00 |
| Symbio Pharmaceuticals Ltd | 5.59bn | -1.96bn | 8.03bn | 109.00 | -- | 1.05 | -- | 1.44 | -48.74 | -48.74 | 139.70 | 170.89 | 0.6009 | 3.36 | 3.73 | 51,281,720.00 | -21.10 | -19.18 | -24.97 | -23.62 | 78.91 | 65.84 | -35.11 | -24.32 | 8.21 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| Stella Pharma Corp | 254.09m | -765.17m | 8.34bn | 46.00 | -- | 3.12 | -- | 32.81 | -25.23 | -25.23 | 8.32 | 85.55 | 0.0637 | 0.0456 | 3.58 | 5,523,718.00 | -19.18 | -- | -20.37 | -- | 82.76 | -- | -301.14 | -- | 11.90 | -1,173.12 | 0.2671 | -- | 128.85 | -- | -1.45 | -- | -- | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.07bn | 8.89bn | 12.00 | -- | 2.82 | -- | -- | -64.96 | -64.96 | 0.00 | 174.81 | 0.00 | -- | -- | 0.00 | -40.62 | -65.86 | -42.95 | -79.11 | -- | -- | -- | -1,094.10 | -- | -- | 0.00 | -- | -- | -- | -45.41 | -- | -- | -- |
Data as of Apr 19 2024. Currency figures normalised to Nippon Chemiphar Co Ltd's reporting currency: Japanese Yen JPY
2.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 29 Mar 2024 | 31.30k | 0.73% |
| Fidelity Management & Research Co. LLCas of 31 Jan 2024 | 20.61k | 0.48% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 15.00k | 0.35% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 14.30k | 0.34% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024 | 6.60k | 0.16% |
| BlackRock Japan Co. Ltd.as of 04 Apr 2024 | 4.30k | 0.10% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 20 Apr 2023 | 2.60k | 0.06% |
| Asset Management One Co., Ltd.as of 04 Apr 2024 | 1.60k | 0.04% |
| Amundi Asset Management SA (Investment Management)as of 03 Apr 2024 | 731.00 | 0.02% |
| Norinchukin Zenkyoren Asset Management Co., Ltd.as of 04 Apr 2024 | 400.00 | 0.01% |
More ▼
Data from 31 Dec 2023 - 11 Apr 2024Source: FactSet Research Systems Inc.
